OPINION

Immunity to COVID-19 and issues of screening for SARS-Cov-2 antibodies

About authors

Pirogov Russian National Research Medical University, Moscow, Russia

Correspondence should be addressed: Nikolay A. Mayanskiy
Ostrovityanova, 1, Moscow, 117997; moc.liamg@yalokin.yiksnayam

Received: 2020-06-01 Accepted: 2020-06-15 Published online: 2020-06-23
|
  1. WHO: Coronavirus disease (COVID-19). Situation Report — 126. Available from: https://www.who.int/docs/default-source/ coronaviruse/situation-reports. Доступ 26 мая 2020.
  2. Sethuraman N, Jeremiah SS, Ryo A. Interpreting Diagnostic Tests for SARS-CoV-2. JAMA. 2020 May 6. DOI: 10.1001/ jama.2020.8259.
  3. Long QX, Liu BZ, Deng HJ, Wu GC, Deng K, Chen YK, et al. Antibody responses to SARS-CoV-2 in patients with COVID-19. Nat Med. 2020 Apr 29. DOI: 10.1038/s41591-020-0897-1.
  4. Kellam P, Barclay W. The dynamics of humoral immune responses following SARS-CoV-2 infection and the potential for reinfection. J Gen Virol. 2020 May 20. DOI: 10.1099/jgv.0.001439.
  5. Wu F, Wang A, Liu M, Wang Q, Chen J, Xia S, et al. Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications. Preprint at medRxiv. Available from: https://doi.org/10.1101/2020.03.30.20047365.
  6. Kirkcaldy RD, King BA, Brooks JT. COVID-19 and Postinfection Immunity: Limited Evidence, Many Remaining Questions. JAMA. 2020 May 11. DOI: 10.1001/jama.2020.7869.
  7. Melgaço JG, Azamor T, Ano Bom APD. Protective immunity after COVID-19 has been questioned: What can we do without SARS-CoV-2-IgG detection? Cell Immunol. 2020 Apr 28; 353: 104114. DOI: 10.1016/j.cellimm.2020.104114.
  8. Ni L, Ye F, Cheng ML, Feng Y, Deng YQ, Zhao H, et al. Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals. Immunity. 2020 May 3. DOI: 10.1016/j.immuni.2020.04.023.
  9. Torres R, Rinder HM. Double-Edged Spike-Are SARS-CoV-2 Serologic Tests Safe Right Now? Lab Med. 2020 May 6; 51 (3): 236–8. DOI: 10.1093/labmed/lmaa025.
  10. Sood N, Simon P, Ebner P, Eichner D, Reynolds J, Bendavid E, et al. Seroprevalence of SARS-CoV-2-Specific Antibodies Among Adults in Los Angeles County, California, on April 10–11, 2020. JAMA. 2020 May 18: e208279. DOI: 10.1001/jama.2020.8279.
  11. Hains DS, Schwaderer AL, Carroll AE, Starr MC, Wilson AC, Amanat F, et al. Asymptomatic Seroconversion of Immunoglobulins to SARS-CoV-2 in a Pediatric Dialysis Unit. JAMA. 2020 May 14: e208438. DOI: 10.1001/jama.2020.8438.
  12. Ismail AA. Serological tests for COVID-19 antibodies: Limitations must be recognized. Ann Clin Biochem. 2020 May 14: 4563220927053. DOI: 10.1177/0004563220927053.
  13. Krammer F, Simon V. Serology assays to manage COVID-19. Science. 2020 May 15: eabc1227. DOI: 10.1126/science.abc1227.
  14. Mathur G, Mathur S. Antibody Testing For Covid-19. Am J Clin Pathol. 2020 May 15: aqaa082. DOI: 10.1093/ajcp/aqaa082.
  15. Metodicheskie ukazaniay MU 3.1.2943-11 “Organizatsiya b provedenie serologicheskogo monitoring sostoyaniay kollectivnogo immunitets k infectsiyam, upravlyaemym sredstavami spetsificheskoi profilaktiki (difteriya, stolbnyakm koklyush, korj, krasnukha, gepatit B)”. Russian.
  16. Available from: https://vademec.ru/news/2020/05/25/mgfoms-opredelil-stoimost-provedeniya-testa-na-antitela-k-covid-19. Доступ 26 мая 2020.